scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Javier Buesa | Q30511654 |
Vicente Monedero | Q43092261 | ||
Jesus Rodriguez-Diaz | Q61858383 | ||
P2860 | cites work | The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection | Q21562434 |
Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection | Q26776155 | ||
X-ray crystallographic structure of the Norwalk virus capsid | Q27619935 | ||
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen | Q27678512 | ||
Human susceptibility and resistance to Norwalk virus infection | Q28190653 | ||
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. | Q30386674 | ||
The human jejunum has an endogenous microbiota that differs from those in the oral cavity and colon | Q33909384 | ||
Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine | Q33916431 | ||
Low prevalence of rotavirus and high prevalence of norovirus in hospital and community wastewater after introduction of rotavirus vaccine in Nicaragua | Q34053403 | ||
Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis | Q34202510 | ||
Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota | Q34372980 | ||
Probiotics and virulent human rotavirus modulate the transplanted human gut microbiota in gnotobiotic pigs. | Q34404931 | ||
Natural history of human rotavirus infection | Q34414965 | ||
Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness | Q34429385 | ||
Enteric bacteria promote human and mouse norovirus infection of B cells | Q34446799 | ||
Replication of human noroviruses in stem cell-derived human enteroids | Q34538562 | ||
L-fucose utilization provides Campylobacter jejuni with a competitive advantage | Q34880976 | ||
Advances in laboratory methods for detection and typing of norovirus | Q34983000 | ||
Trans activity of the norovirus Camberwell proteinase and cleavage of the N-terminal protein encoded by ORF1. | Q35020660 | ||
Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics | Q35107678 | ||
Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status. | Q35147973 | ||
Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. | Q35443349 | ||
Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection | Q35458229 | ||
A working model of how noroviruses infect the intestine | Q35568903 | ||
Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype | Q35571282 | ||
Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli. | Q43150629 | ||
Interaction between probiotic lactic acid bacteria and canine enteric pathogens: a risk factor for intestinal Enterococcus faecium colonization? | Q43216404 | ||
Letter: Virus particles in gastroenteritis | Q43950605 | ||
Norwalk virus genome cloning and characterization | Q44643083 | ||
Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals | Q45732225 | ||
Decreased pathogenicity of murine leukemia virus-Moloney in gnotobiotic mice | Q45832909 | ||
Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India | Q46164556 | ||
Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors | Q46243057 | ||
Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens | Q47556965 | ||
Bacteria Facilitate Enteric Virus Co-infection of Mammalian Cells and Promote Genetic Recombination. | Q47559365 | ||
High temporal and inter-individual variation detected in the human ileal microbiota | Q48064015 | ||
An outbreak of gastroenteritis during school trip caused by serotype G2 group A rotavirus | Q49302841 | ||
Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. | Q51930599 | ||
Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. | Q54294858 | ||
Association of histo-blood group antigens and susceptibility to norovirus infections. | Q55040149 | ||
Lactobacilli binding human A-antigen expressed in intestinal mucosa | Q57709946 | ||
Indigenous microbes and their soluble factors differentially modulate intestinal glycosylation steps in vivo. Use of a "lectin assay" to survey in vivo glycosylation changes | Q81210660 | ||
Intestinal fucose as a mediator of host-microbe symbiosis. | Q35655273 | ||
Secretor Status Is Strongly Associated with Microbial Alterations Observed during Pregnancy | Q35731477 | ||
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner | Q35943850 | ||
Characterisation of a household norovirus outbreak occurred in Valencia (Spain). | Q35954493 | ||
Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease. | Q36071994 | ||
Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana | Q36179680 | ||
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens | Q36246385 | ||
Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner | Q36293984 | ||
Human norovirus binding to select bacteria representative of the human gut microbiota | Q36296722 | ||
Dysbiosis and the immune system | Q36297601 | ||
L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium | Q36313802 | ||
Fucose sensing regulates bacterial intestinal colonization | Q36456598 | ||
Successful transmission of a retrovirus depends on the commensal microbiota | Q36460257 | ||
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein | Q36685153 | ||
Enterobacter cloacae inhibits human norovirus infectivity in gnotobiotic pigs. | Q36835594 | ||
Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. | Q37123423 | ||
Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants. | Q37297566 | ||
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens | Q37302434 | ||
Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs. | Q37400488 | ||
Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus | Q37576028 | ||
Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study | Q37728321 | ||
Relevance of secretor status genotype and microbiota composition in susceptibility to rotavirus and norovirus infections in humans | Q37728352 | ||
Interaction of probiotics and pathogens--benefits to human health? | Q37736076 | ||
Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: global distribution of genogroups, genotypes and GII.4 variants. | Q38065515 | ||
Histo-blood group antigens: a common niche for norovirus and rotavirus | Q38194256 | ||
Host-pathogen co-evolution and glycan interactions | Q38226895 | ||
Norwalk virus infection associates with secretor status genotyped from sera | Q38441825 | ||
Mechanisms and consequences of intestinal dysbiosis. | Q38869770 | ||
Intestinal microbiota promote enteric virus replication and systemic pathogenesis | Q39306213 | ||
The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein | Q40011693 | ||
Rotavirus Vaccine Response Correlates with the Infant Gut Microbiota Composition in Pakistan | Q40048009 | ||
New perspectives regarding the antiviral effect of vitamin A on norovirus using modulation of gut microbiota | Q40126531 | ||
Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland | Q40600779 | ||
Rotavirus infection and histo-blood group antigens in the children hospitalized with diarrhoea in China | Q40636479 | ||
Association of elevated rotavirus-specific antibody titers with HBGA secretor status in Swedish individuals: The FUT2 gene as a putative susceptibility determinant for infection | Q40958697 | ||
Binding to histo-blood group antigen-expressing bacteria protects human norovirus from acute heat stress. | Q41560758 | ||
Human intestinal organoids express histo-blood group antigens, bind norovirus VLPs, and support limited norovirus replication | Q41925105 | ||
A model of host-microbial interactions in an open mammalian ecosystem | Q42634168 | ||
Serotype G9 rotavirus infections in adults in Sweden | Q42721947 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gastroenteritis | Q156103 |
host-pathogen interaction | Q5909198 | ||
Rotavirus | Q164778 | ||
norovirus | Q1142751 | ||
gastrointestinal tract | Q11829360 | ||
microbiota | Q104117645 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P577 | publication date | 2018-02-24 | |
P1433 | published in | Viruses | Q7935305 |
P1476 | title | The Interactions between Host Glycobiology, Bacterial Microbiota, and Viruses in the Gut | |
P478 | volume | 10 |